Gut Microbiome Dysbiosis in Metabolic Syndrome: Current Evidence and Emerging Perspectives
Nutrients · 13.05.2026 · 18 (10) · 1540
DOI: 10.3390/nu18101540 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 13.05.2026. Verfasst von Fatma Shehata und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Institute for Mental and Physical Health and Clinical Translation, Deakin University, Geelong, VIC 3220, Australia. Hauptthemen laut MEDLINE: Metabolic Syndrome, Dysbiosis, Gastrointestinal Microbiome. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 184 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The gut microbiota plays a crucial role in human metabolism, and disruptions to its composition, particularly reductions in bacterial diversity, have been increasingly associated with the development of metabolic syndrome (MetS). MetS encompasses a constellation of interrelated metabolic risk factors, including central obesity, insulin resistance, dyslipidemia, and hypertension, which collectively elevate the risk of cardiovascular and cerebrovascular disease. A comprehensive understanding of the mechanisms underlying MetS is therefore critical for the development of effective preventive and therapeutic strategies. Complex interactions between the gut microbiota and host metabolic pathways are mediated by multiple factors, including microbial metabolites, inflammatory signaling, and host immune responses. This narrative review characterizes the clinical manifestations of MetS and alterations in gut microbiota composition, characterized by an overrepresentation of potentially pathogenic taxa and a concomitant decline in beneficial microbial species. In addition, we discuss current and emerging approaches to microbiota modulation, including prebiotics, probiotics, synbiotics, postbiotics, and fecal microbiota transplantation, and evaluate their potential roles in the prevention and management of MetS. We identify critical evidence gaps and propose research priorities for evidence-based clinical strategies for MetS management and prevention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Institute for Mental and Physical Health and Clinical Translation, Deakin University, Geelong, VIC 3220, Australia.
- The Royal Melbourne Hospital, The University of Melbourne, Parkville, VIC 3050, Australia.
ORCID-Profile: Fatma Shehata, Karen M Dwyer, Sean L McGee, Leni R Rivera
Zitieren
APA
Shehata, F., Dwyer, K. M., McGee, S. L., & Rivera, L. R. (2026). Gut Microbiome Dysbiosis in Metabolic Syndrome: Current Evidence and Emerging Perspectives. Nutrients, 18(10), 1540. https://doi.org/10.3390/nu18101540
Vancouver
Shehata F, Dwyer KM, McGee SL, Rivera LR. Gut Microbiome Dysbiosis in Metabolic Syndrome: Current Evidence and Emerging Perspectives. Nutrients. 2026;18(10):1540. doi:10.3390/nu18101540
BibTeX
@article{Shehata2026,
author = {Shehata, Fatma and Dwyer, Karen M and McGee, Sean L and Rivera, Leni R},
title = {Gut Microbiome Dysbiosis in Metabolic Syndrome: Current Evidence and Emerging Perspectives},
journal = {Nutrients},
year = {2026},
volume = {18},
number = {10},
pages = {1540},
doi = {10.3390/nu18101540}
}
EUVIMED